Research News and Research

RSS

Pre-clinical study of Cardio3 BioSciences' proprietary C-Cath catheter announced

Cardio3 BioSciences, a leading Belgian biotechnology company specialising in cell-based therapies for the treatment of cardiovascular diseases, announced today promising results in a pre-clinical study of its proprietary C-Cath(R) catheter which is under development to administer a range of bio-therapeutics to the heart. C-Cath is designed to take into account organ tissue structure and properties to maximize patients' safety, improve performance and increase user confidence during the injection procedure.

2 Mar 2010

Prenatal cocaine exposure affects sustained attention and self-regulated behavior in children

Children exposed to cocaine in the womb face serious consequences from the drug, but fortunately not in certain critical physical and cognitive areas as previously believed, according to a new comprehensive review of research on the subject from scientists at the University of Maryland School of Medicine. When a pregnant woman uses cocaine, it can interrupt the flow of nutrients and oxygen to the baby, putting such children at risk for premature birth, low birth weight and many other problems.

2 Mar 2010

Daily consumption of chlorella can help maintain healthy body

Americans' dietary habits have been scrutinized for being dependent on processed, refined and incomplete foods. This has left many Americans to reassess the foods they eat and essentially reconstruct their personal food pyramids.

2 Mar 2010

Intercell AG's revenues for full year 2009 increase 10.6%

Today, the biotech-vaccine company Intercell AG announced its financial results for Q4 and the preliminary results for the full financial year 2009, and presented an update on the Company's development programs.

2 Mar 2010

Sea squirts help in fight against Alzheimer's disease

Alzheimer's disease affects an estimated 27 million people worldwide. It is the most common form of age-related dementia, possibly the most feared disease of old age. There is no cure, and the available drugs only help to relieve symptoms without slowing progression of the disease. One of the characteristic changes in the brains of Alzheimer's patients is the accumulation of plaques and tangles; currently, the best hope for curing or at least slowing the disease lies in developing drugs that target this buildup.

2 Mar 2010

Clot-busting drug therapy after stroke beneficial for women

New research shows women who don't receive a clot-busting drug after a stroke fare worse than men who are not treated. The study is published in the March 2, 2010, print issue of Neurology®, the medical journal of the American Academy of Neurology.

2 Mar 2010

Future work may uncover links between insulin use and cancer risk, say researchers

The benefits of using insulin to treat diabetes far outweigh the risks, but a review just published online by IJCP, the International Journal of Clinical Practice, suggests that commonly used diabetes therapies may differ from each other when it comes to their influence on cancer risk.

2 Mar 2010

InterSystems Ensemble platform enables first successful electronic transmission of genetic data

InterSystems Corporation, the global leader in software for connected healthcare, today announced that InterSystems Ensemble® was the software platform for the first-ever successful electronic transmission of comprehensive genetic data. The information was sent cross-country from Boston-based Partners HealthCare Center for Personalized Genetic Medicine (PCPGM) to Intermountain HealthCare in Salt Lake City, Utah. The announcement about reaching this milestone in personalized medicine came at the HIMSS10 conference.

2 Mar 2010

Inovio Biomedical's SynCon preventive DNA vaccine receives approval in Korea for Phase I clinical trial

Inovio Biomedical Corporation, a leader in DNA vaccine design, development and delivery, announced today that its affiliate VGX International Inc. has received approval in Korea to begin a Phase I clinical trial in healthy volunteers for Inovio’s SynCon™ preventive DNA vaccine (VGX-3400) targeting H5N1 avian influenza.

2 Mar 2010

Visually impaired children benefit from earlier introduction to long cane

When "T" started kindergarten, she was an independent, confident child who was fully able to move about in her new environment—even though she was the only visually impaired child in her school and used a long cane. T was born in 2003 with Leber's congenital amaurosis, a rare inherited eye disease, and has no light perception. She was introduced to the long cane at the early age of 14 months to foster her independence of mobility and functioning.

2 Mar 2010

Consumption of garlic reduces level of potential carcinogenic processes

Researchers have designed a urine test that can simultaneously measure the extent of a potential carcinogenic process and a marker of garlic consumption in humans.

2 Mar 2010

Most strains of pandemic H1N1 flu virus resist Tamiflu, say scientists

If the behavior of the seasonal form of the H1N1 influenza virus is any indication, scientists say that chances are good that most strains of the pandemic H1N1 flu virus will become resistant to Tamiflu, the main drug stockpiled for use against it.

2 Mar 2010

Scientists show omega-3 fatty acid and its derivatives kill neuroblastoma cancer cells

The next treatment for cancer might come from fish says a new research report published in the March 2010 print edition of the FASEB Journal (http://www.fasebj.org). In the report, scientists show that the omega-3 fatty acid, "docosahexaenoic acid" or "DHA," and its derivatives in the body kill neuroblastoma cancer cells.

2 Mar 2010

Sigma-Aldrich unveils new Sigma Life Science brand and website platform

Sigma-Aldrich® today unveiled its new Sigma® Life Science brand and website platform, designed to elevate the Company's current focus on biology and provide a single destination where researchers can access deep biological knowledge and market-leading products and technologies.

2 Mar 2010

Two-week U.N. meeting on gender equality kicks off Monday

Ahead of the two-week U.N. Commission on the Status of Women (CSW), which kicks off Monday in New York, Inter Press Service features a Q&A with Thoraya Ahmed Obaid, executive director of the U.N. Population Fund (UNFPA), who highlights some of the goals of the meeting. As part of CSW, world leaders are expected to discuss gender equality in the context of the implementation of the 1995 Beijing Platform for Action, the 1994 Program of Action of the International Conference on Population and Development (ICPD) and the U.N.'s Millennium Development Goals (MDG).

2 Mar 2010

Simvastatin impairs ability of macrophages to kill pathogens, and enhances cytokine production

Simvastatin might help us control our cholesterol, but when it comes to infection, it's an entirely different story says a new research study published in the Journal of Leukocyte Biology. In the research report, scientists from Italy show that simvastatin delivers a one-two punch to the immune system. First it impairs the ability of specialized immune cells, called macrophages, to kill pathogens. Then, it enhances production of molecules, called cytokines, which trigger and sustain inflammation.

2 Mar 2010

ZyGEM introduces new RNAGEM Tissue RNA extraction kits

ZyGEM Corp. Ltd., a provider of innovative enzyme-based products for DNA and RNA extraction and other life sciences applications, today announced the launch of its new RNAGEM™ Tissue RNA extraction kits. This product represents a significant advance in sample preparation for RNA-based testing and analysis.

2 Mar 2010

Some U.S. troops stay in Haiti; Aid officials prepare for rainy season

Kenneth Merten, the U.S. ambassador to Haiti, said on Thursday that American troops would stay in the country to aid in its recovery, Agence France-Presse reports. "There are about 6,500 soldiers in Haiti at the moment. There were some 20,000 for the emergency effort launched in the wake of January 12," Merten said. "What is planned for the moment is more and more staff from USAID on the ground and fewer and fewer troops. Gradually, they'll leave. In my opinion, we will need some American troops to stay here for the foreseeable future" (2/25).

2 Mar 2010

Praxis to provide patient recruitment services for international type 2 diabetes study

Praxis, a company specializing in centralized patient recruitment for clinical research studies, will provide patient recruitment services to a top 20 pharmaceutical company for an international study on type 2 diabetes. The study explores an investigational drug’s effectiveness for maintaining glycemic control for individuals newly diagnosed with type 2 diabetes.

2 Mar 2010

WuXi PharmaTech, JANSSEN division announce collaboration for preclinical services

WuXi PharmaTech, a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, today announced it has reached an agreement with Johnson & Johnson Pharmaceutical Research & Development, a division of Janssen Pharmaceutica N.V. (JANSSEN), to collaborate in the area of preclinical services.

2 Mar 2010

Research News and Research

Pre-clinical study of Cardio3 BioSciences' proprietary C-Cath catheter announced

Prenatal cocaine exposure affects sustained attention and self-regulated behavior in children

Daily consumption of chlorella can help maintain healthy body

Intercell AG's revenues for full year 2009 increase 10.6%

Sea squirts help in fight against Alzheimer's disease

Clot-busting drug therapy after stroke beneficial for women

Future work may uncover links between insulin use and cancer risk, say researchers

InterSystems Ensemble platform enables first successful electronic transmission of genetic data

Inovio Biomedical's SynCon preventive DNA vaccine receives approval in Korea for Phase I clinical trial

Visually impaired children benefit from earlier introduction to long cane

Consumption of garlic reduces level of potential carcinogenic processes

Most strains of pandemic H1N1 flu virus resist Tamiflu, say scientists

Scientists show omega-3 fatty acid and its derivatives kill neuroblastoma cancer cells

Sigma-Aldrich unveils new Sigma Life Science brand and website platform

Two-week U.N. meeting on gender equality kicks off Monday

Simvastatin impairs ability of macrophages to kill pathogens, and enhances cytokine production

ZyGEM introduces new RNAGEM Tissue RNA extraction kits

Some U.S. troops stay in Haiti; Aid officials prepare for rainy season

Praxis to provide patient recruitment services for international type 2 diabetes study

WuXi PharmaTech, JANSSEN division announce collaboration for preclinical services

A guide to advancing biotherapeutic research eBook

Latest eBooks

A practical guide to lipid nanoparticle formulation and resizing

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Managing vibration in IVF laboratories

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence